Loading provider…
Loading provider…
Psychiatry Physician in Staten Island, NY
NPI: 1538143680Primary Employer
Richmond Behavioral Associates, LLC
rbany.com
HQ Phone
Get MD Mark's Phone Numberphone_androidMobile
Get MD Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NJ State Medical License
1984 - 2027
NY State Medical License
1983 - 2027

American Board of Psychiatry and Neurology
Psychiatry
Stony Brook Medicine/University Hospital
Residency • Psychiatry
1984 - 1987
Albert Einstein College of Medicine/Montefiore (New Rochelle)
Internship • Transitional Year
1983 - 1984
Universidad Autonoma de Guadalajara
Medical School
Until 1981
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 90836Psychotherapy with evaluation and management visit, 45 minutes | 120 | 235 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 97 | 145 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 66 | 115 |
| 4 | 90833Psychotherapy, 30 minutes | 39 | 66 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 27 | 27 |
Relapse in delusional depression: A retrospective study of the course of treatment
Authors: Thomas A. Aronson, Sashi Shukla, Krishnareddy S. Gujavarty, Anne L. Hoff, Mark DiBuono, Edna Khan
Publication Date: 1988-01
Lead Sponsor: Sumitomo Pharma America, Inc.
Intervention / Treatment: DRUG: Dasotraline, DRUG: Placebo Comparator
Lead Sponsor: Sumitomo Pharma America, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Lurasidone, DRUG: Lurasidone 20 mg daily
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Solanezumab